1 ... 19 20 21 22 23 24 25 26 ... 29

Barium and barium compounds

səhifə23/29
tarix24.02.2018
ölçüsü0.67 Mb.

:

publications
publications -> Kapag ang Babaeng Mahal mo ay mayroong Maagang Kanser sa Suso
publications -> Thomas reilly
publications -> Governance and Democracy katarsis survey Paper
publications -> Memahami makna menjadi pria metroseksual
publications -> Revisiting elisabeth kubler-ross: pastoral and clinical implications of the death and dying stage model in the caring process

Barium and barium compounds

33

APPENDIX 2 — CICAD PEER REVIEW

The draft CICAD on barium and barium compounds was

sent for review to institutions and organizations identified by

IPCS after contact with IPCS national contact points and

Participating Institutions, as well as to identified experts.

Comments were received from:

M. Ball, Health and Safety Executive, Bootle, Merseyside,

United Kingdom 

M. Baril, International Programme on Chemical Safety/

Institut de Recherche en Santé et en Sécurité du Travail

du Québec, Montreal, Quebec, Canada 

D. Bayliss, National Center for Environmental Assessment,

US Environmental Protection Agency, Washington, DC,

USA

R. Benson, US Environmental Protection Agency, Denver,

CO, USA

T. Berzins, National Chemicals Inspectorate, Solna,

Sweden

R. Chhabra, Department of Health and Human Services,

National Institute of Environmental Health Sciences,

Research Triangle Park, NC, USA 

P. Edwards, Protection of Health Division, Department of

Health, London, United Kingdom

L. Hall, Pharmacokinetics Branch, Environmental

Toxicology Division, National Health and Environmental

Effects Research Laboratory, US Environmental

Protection Agency, Research Triangle Park, NC, USA 

H. Nagy, National Institute for Occupational Safety and

Health, Washington, DC, USA 

E. Ohanian, Office of Water, US Environmental

Protection Agency, Washington, DC, USA

B. Sjögren, Toxicology and Risk Assessment, Swedish

National Institute for Working Life, Stockholm, Sweden

S. Soliman, Department of Pesticide Chemistry, Faculty

of Agriculture, Alexandria University, Alexandria, Egypt

M. Vojtísek, National Institute of Public Health,

Srobarova, Prague, Czech Republic

P. Yao, Ministry of Health, Institute of Occupational

Medicine, Chinese Academy of Preventive Medicine,

Beijing, People’s Republic of China 

K. Ziegler-Skylakakis, GSF - National Research Center for

Environment and Health, Neuherberg, Oberschleissheim,

Germany


A. Zitting, Unit of Risk Assessment, Department of

Toxicology and Industrial Hygiene, Finnish Institute of

Occupational Health, Helsinki, Finland

APPENDIX 3 — CICAD FINAL REVIEW

BOARD

Helsinki, Finland, 26–29 June 2000

Members

Mr H. Ahlers, Education and Information Division, National

Institute for Occupational Safety and Health, Cincinnati, OH,

USA


Dr T. Berzins, National Chemicals Inspectorate (KEMI), Solna,

Sweden


Dr R.M. Bruce, Office of Research and Development, National

Center for Environmental Assessment, US Environmental

Protection Agency, Cincinnati, OH, USA

Mr R. Cary, Health and Safety Executive, Liverpool, United

Kingdom (Rapporteur)

Dr R.S. Chhabra, General Toxicology Group, National Institute

of Environmental Health Sciences, Research Triangle Park, NC,

USA


Dr H. Choudhury, National Center for Environmental Assessment,

US Environmental Protection Agency, Cincinnati, OH, USA

Dr S. Dobson, Centre for Ecology and Hydrology, Monks Wood,

Abbots Ripton, United Kingdom (Chairman)

Dr H. Gibb, National Center for Environmental Assessment, US

Environmental Protection Agency, Washington, DC, USA

Dr R.F. Hertel, Federal Institute for Health Protection of

Consumers and Veterinary Medicine, Berlin, Germany

Ms K. Hughes, Priority Substances Section, Environmental

Health Directorate, Health Canada, Ottawa, Ontario, Canada

Dr G. Koennecker, Chemical Risk Assessment, Fraunhofer

Institute for Toxicology and Aerosol Research, Hanover,

Germany

Ms M. Meek, Existing Substances Division, Environmental

Health Directorate, Health Canada, Ottawa, Ontario, Canada

Dr A. Nishikawa, Division of Pathology, Biological Safety

Research Centre, National Institute of Health Sciences, Tokyo,

Japan


Dr V. Riihimäki, Finnish Institute of Occupational Health,

Helsinki, Finland

Dr J. Risher, Agency for Toxic Substances and Disease Registry,

Division of Toxicology, US Department of Health and Human

Services, Atlanta, GA, USA

Professor K. Savolainen, Finnish Institute of Occupational

Health, Helsinki, Finland (Vice-Chairman)

Dr J. Sekizawa, Division of Chem-Bio Informatics, National

Institute of Health Sciences, Tokyo, Japan

Dr S. Soliman, Department of Pesticide Chemistry, Faculty of

Agriculture, Alexandria University, Alexandria, Egypt

Concise International Chemical Assessment Document 33

34

Ms D. Willcocks, National Industrial Chemicals Notification and

Assessment Scheme, Sydney, NSW, Australia

Observers

Dr R.J. Lewis (representative of European Centre for

Ecotoxicology and Toxicology of Chemicals), Epidemiology and

Health Surveillance, ExxonMobil Biomedical Sciences, Inc.,

Annandale, NJ, USA

Secretariat

Dr A. Aitio, International Programme on Chemical Safety, World

Health Organization, Geneva, Switzerland (Secretary)

Dr P.G. Jenkins, International Programme on Chemical Safety,

World Health Organization, Geneva, Switzerland

Dr M. Younes, International Programme on Chemical Safety,

World Health Organization, Geneva, Switzerland

Prepared in the context of cooperation between the International

Programme on Chemical Safety and the European Commission 

© IPCS  2000

SEE IMPORTANT INFORMATION ON THE BACK.

IPCS

International

Programme on

Chemical Safety

BARIUM

1052

October 1999

CAS No: 7440-39-3

RTECS No: CQ8370000

UN No: 1400

Ba

Atomic mass: 137.3

TYPES OF

HAZARD/

EXPOSURE

ACUTE HAZARDS/SYMPTOMS

PREVENTION

FIRST AID/FIRE FIGHTING

FIRE

Flammable. Many reactions may

cause fire or explosion.

NO open flames, NO sparks, and

NO smoking. NO contact with water.

Special powder, dry sand, NO

hydrous agents, NO water.

EXPLOSION

Finely dispersed particles form

explosive mixtures in air.

Prevent deposition of dust; closed

system, dust explosion-proof

electrical equipment and lighting.

EXPOSURE

PREVENT DISPERSION OF DUST!

STRICT HYGIENE!

Inhalation

Cough. Sore throat.

Local exhaust or breathing

protection.

Fresh air, rest. Refer for medical

attention.

Skin

Redness.


Protective gloves.

Remove contaminated clothes.

Rinse skin with plenty of water or

shower. Refer for medical attention.

Eyes

Redness. Pain.

Safety goggles.

First rinse with plenty of water for

several minutes (remove contact

lenses if easily possible), then take

to a doctor.

Ingestion

Do not eat, drink, or smoke during

work.

Rinse mouth. Refer for medical

attention.

SPILLAGE DISPOSAL

PACKAGING & LABELLING

Sweep spilled substance into sealable containers.

Carefully collect remainder, then remove to safe

place. Chemical protection suit including

self-contained breathing apparatus. Do NOT wash

away into sewer.

UN Hazard Class: 4.3

UN Pack Group: II

EMERGENCY RESPONSE

STORAGE

Transport Emergency Card: TEC (R)-43G12

Separated from halogenated solvents, strong oxidants, acids. Dry. Keep

under inert gas, oil or oxygen-free liquid.




Dostları ilə paylaş:

©2018 Учебные документы
Рады что Вы стали частью нашего образовательного сообщества.
?


barli-konkursa-10.html

barli-konkursa-6.html

barli-mamanditara-arnalan-2.html

barli-mektep.html

barli-saat-sani-135--.html